Farzana Muhib

Program Officer
Phone: 
+1.202.470.5731

Farzana Muhib joined Results for Development Institute in May 2008. She currently works on the aids2031 Costs and Financing Working Group and is responsible for the management of project activities. Before joining R4D, she worked at Johns Hopkins University on the Pneumococcal Vaccine Accelerated Development and Introduction Project as the Research Project Manager coordinating over 40 research and surveillance projects. Ms. Muhib has extensive international experience and has worked in South and South West Asia. She served as the PneumoADIP’s focal point for the EMRO region on pneumococcal vaccine, and helped to set up surveillance for pneumococcal disease in several countries including Mongolia and Pakistan. Ms. Muhib has also worked on domestic health issues during her time at the Centers for Disease Control, where she was a survey coordinator for a National HIV/AIDS Behavioral Research project. She also developed a technical assistance manual for state and local health departments to conduct rapid assessments of HIV/AIDS risk behaviors.

Ms. Muhib holds a Masters in Public Health from the Rollins School of Public Health at Emory University, where she concentrated in International Health and Epidemiology. She also obtained her Masters of Arts in Law and Diplomacy from the Fletcher School of Law and Diplomacy at Tufts University, focusing on Development Economics and South West Asian Civilizations.

Related News

In preparation for World AIDS Day, the BBC invited Farzana Muhib, R4D's coordinator for the aids2031 Costs and Financing Project, to discuss future cost and financing scenarios for the global AIDS epidemic in their Health Check spotlight, "The Future for HIV/AIDS Funding."  Ms. Muhib highlighted the importance of "tough choice" spending policy decisions and more efficient management of resources now in order to curb future costs of the epidemic and achieve better health outcomes.

By the year 2031, the AIDS pandemic will enter its 50th year, and funding needed to fight the pandemic in developing countries could reach as much as $35 billion annually – unless wise choices are made today to spend more efficiently and focus on prevention activities that can lower the number of new infections in the future and moderate costs for treatment and other measures to mitigate the negative impacts of AIDS on individuals and their communities.

Related Publications & Resources

This paper examines potential long-term costs and financing options for the global AIDS response under four different scenarios and provides policy recommendations based on projected epidemiological and financial impacts.